NewsPressmeddelande HAMLET Pharma initiates a GLP study to evaluate if intracerebral infusion of the drug candidate Alpha1H has any toxic effects
News Hamlet Pharma is proud to announce detailed timelines for the completion of the Phase I/II bladder cancer study
News The therapeutic effect of Alpha1H, Hamlet Pharma’s drug candidate, increases substantially with the treatment dose
